Consequently, this study proposes that TNFα treatment can be utilized as a simple in vitro model to investigate the pathophysiology of mitochondrial dysfunction and associated metabolic complications such as oxidative stress and insulin resistance in adipocytes, and to screen potential anti-obesity therapeutics. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.